1,2,4-triazole has been researched along with Neoplasms in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (63.64) | 24.3611 |
2020's | 4 (36.36) | 2.80 |
Authors | Studies |
---|---|
Kumar, K; Rathod, B | 1 |
Ganipisetti, H; Kumar Putta, VN; Majhi, D; Mallisetty, NM; Sirisilla, R | 1 |
Abdel-Aziz, LM; Abdel-Aziz, MM; El-Shanawani, AA; Elbaramawi, SS; Elbatreek, MH; Zawal, AG | 1 |
Duan, WG; Li, FY; Li, QM; Lin, GS; Lu, SZ; Zhu, XP | 1 |
Ali, I; Choi, G; Go, A; Lee, J; Lee, K | 1 |
Abbas Bukhari, SN; Abdel-Aziz, M; Abdel-Rahman, HM; Abdelazeem, AH; El-Sherief, HAM; Youssif, BGM | 1 |
Chacón-Huete, F; Chen, F; Covone, J; Forgione, P; Kwan, DH; Petrella, A; Tsai, TW; Yu, CC; Zhang, X | 1 |
Abdel-Aziz, M; Abuo-Rahma, Gel-D; Ali, TF; Beshr, EA | 1 |
Diao, PC; Li, Q; Li, YH; Yang, HK; You, WW; Zhang, B; Zhao, PL | 1 |
Anderes, K; Chevrel, MC; Drygin, D; Haddach, M; Macalino, D; Nédellec, AS; O'Brien, SE; Pierre, F; Regan, CF; Ryckman, DM; Siddiqui-Jain, A; Stefan, E; Streiner, N | 1 |
Benci, K; Klobučar, M; Kraljević Pavelić, S; Mandić, L; Mintas, M; Pavelić, K; Sedić, M; Suhina, T; Wittine, K | 1 |
1 review(s) available for 1,2,4-triazole and Neoplasms
Article | Year |
---|---|
Synthetic and Medicinal Perspective of 1,2,4-Triazole as Anticancer Agents.
Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles | 2022 |
10 other study(ies) available for 1,2,4-triazole and Neoplasms
Article | Year |
---|---|
Synthesis and Biological Activity Evaluation of Pyrazole-1,2,4-triazole Hybrids: A Computer-aided Docking Studies.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Pyrazoles; Staphylococcus aureus; Structure-Activity Relationship; Triazoles | 2023 |
Design, synthesis, in vitro and in silico evaluation of novel substituted 1,2,4-triazole analogues as dual human VEGFR-2 and TB-InhA inhibitors.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Drug Design; Humans; Molecular Docking Simulation; Molecular Structure; Neoplasms; Oxidoreductases; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2 | 2023 |
Synthesis and Antiproliferative Evaluation of Novel Longifolene-Derived Tetralone Derivatives Bearing 1,2,4-Triazole Moiety.
Topics: Cell Proliferation; Hep G2 Cells; Humans; Magnetic Resonance Spectroscopy; MCF-7 Cells; Neoplasms; Sesquiterpenes; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Tetralones; Triazoles | 2020 |
Discovery of novel [1,2,4]triazolo[4,3-a]quinoxaline aminophenyl derivatives as BET inhibitors for cancer treatment.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Evaluation, Preclinical; Half-Life; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Neoplasms; Nuclear Proteins; Protein Structure, Tertiary; Proto-Oncogene Proteins c-myc; Quinoxalines; Rats; Structure-Activity Relationship; Triazoles | 2017 |
Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Molecular Docking Simulation; Neoplasms; Structure-Activity Relationship; Triazoles | 2018 |
A High-Throughput Glycosyltransferase Inhibition Assay for Identifying Molecules Targeting Fucosylation in Cancer Cell-Surface Modification.
Topics: Drug Screening Assays, Antitumor; Enzyme Inhibitors; Fucose; Fucosyltransferases; Glycosylation; High-Throughput Screening Assays; Humans; Neoplasms; Small Molecule Libraries; Triazoles | 2019 |
1,2,4-Triazole/oxime hybrids as new strategy for nitric oxide donors: Synthesis, anti-inflammatory, ulceroginicity and antiproliferative activities.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Edema; Humans; Male; Neoplasms; Nitric Oxide Donors; Oximes; Rats; Stomach Ulcer; Triazoles | 2014 |
Design, synthesis, and biological evaluation of novel alkylsulfanyl-1,2,4-triazoles as cis-restricted combretastatin A-4 analogues.
Topics: Antineoplastic Agents; Bibenzyls; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Neoplasms; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2017 |
7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: a novel class of Pim kinase inhibitors with potent cell antiproliferative activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Leukemia; Naphthyridines; Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-pim-1; Triazoles | 2011 |
Novel coumarin derivatives containing 1,2,4-triazole, 4,5-dicyanoimidazole and purine moieties: synthesis and evaluation of their cytostatic activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coumarins; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Imidazoles; MCF-7 Cells; Molecular Structure; Neoplasms; Nucleosides; Purines; Structure-Activity Relationship; Triazoles | 2012 |